Dentsply Sirona Swings to 3Q Loss of 1 Cent a Share
XRAY sits 21% above its 52-week low of $8.32.
Summary
Dentsply Sirona posted a third-quarter loss of 1 cent per share, a reversal from the $0.18 EPS it reported in Q2 2026, on sales of $836M and a net loss of $2M, while adjusted EPS came in at 29 cents. That prior quarter's profit was itself propped up by $44M in tariff refunds and a new restructuring plan, so the swing back into the red shows the underlying business is not yet carrying itself. The company is already operating with its dividend suspended to conserve cash and loosened leverage covenants through year-end 2026, so a quarterly loss keeps balance-sheet pressure front and center. It now sets its 2026 sales outlook at $3.5B and sees full-year 2026 adjusted EPS of $1.20 to $1.30.
At the time of this announcement, XRAY was trading at $10.06 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2B. The 52-week trading range was $8.32 to $14.76. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.